Yu Jonathan Yen-Wen sold $22K of IRON
Yu Jonathan Yen-Wen (Chief Operating Officer) sold 300 shares of Disc Medicine, Inc. (IRON) at $72.50 on 2026-06-26 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This provides transparency on officer trading activity but does not introduce new company performance, product, or regulatory information.
Market read
Traders may briefly reassess sentiment around insider behavior, but the pre-arranged nature and small size limit decision impact.
What to watch
The sale size is modest (300 shares) and the plan is pre-arranged, which reduces interpretability versus unscheduled sales.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).
Ticker impact
Disc Medicine COO Yu Jonathan Yen-Wen sold 300 shares in an open-market transaction at $72.50 on 2026-06-26 under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this Form 4 sale; any reaction would be short-lived.
The filing is a small, pre-planned open-market sale by an officer; it does not disclose new fundamentals, guidance, or regulatory/operational events.
Market effects
No clear sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated officer selling can coincide with internal risk management; traders may still watch for follow-on sales or changes in trading patterns.
Key entities
- issuerDisc Medicine, Inc.
Company whose insider transaction is disclosed via SEC Form 4.
- insiderYu Jonathan Yen-Wen
Chief Operating Officer who sold 300 shares under a 10b5-1 plan.
